Recurrent mutations in SRSF2 globally affected the RNA binding and splicing process, such as the hnRNP family of protein, resulting in poor clinical outcomes in myelodysplastic syndromes.12 This evidence concerns the gene SRSF2 and myelodysplastic syndrome.